Search research articles
Contact Us
Filters
Showing results (201-210 of 222) with videos related to
Page
of 23
Sort By:
Scientific Reports
|
November 3, 2020
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
Adrian Georg Simon, Yuri Tolkach, Laura Kristin Esser, et al.
Cancers
|
March 25, 2022
CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
Christine Sanders, Almotasem Salah M Hamad, Susanna Ng, et al.
The Journal of Urology
|
May 8, 2018
Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer
Sebastian L Hofbauer, Andreas Maxeiner, Beatrice Kittner, et al.
Journal of Cellular and Molecular Medicine
|
February 21, 2009
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
Monika Jung, Hans-Joachim Mollenkopf, Christina Grimm, et al.
The American Journal of Pathology
|
March 26, 2011
The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro
Josefine Gerhardt, Corinna Steinbrech, Oralea Büchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2015
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz, et al.
Oncotarget
|
December 2, 2015
Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer
Sebastian Meller, Hellmuth-A Meyer, Bianca Bethan, et al.
Oncogene
|
September 4, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis
Mohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy, et al.
Plos One
|
April 26, 2012
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis
Juan P Patron, Annika Fendler, Matthias Bild, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
January 30, 2024
Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study
Moritz Wambach, Matteo Montani, Josefine Runz, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 222) with videos related to
Sort By:
Page
of 23
Scientific Reports
|
November 3, 2020
Mitophagy-associated genes PINK1 and PARK2 are independent prognostic markers of survival in papillary renal cell carcinoma and associated with aggressive tumor behavior
Adrian Georg Simon, Yuri Tolkach, Laura Kristin Esser, et al.
Cancers
|
March 25, 2022
CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
Christine Sanders, Almotasem Salah M Hamad, Susanna Ng, et al.
The Journal of Urology
|
May 8, 2018
Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer
Sebastian L Hofbauer, Andreas Maxeiner, Beatrice Kittner, et al.
Journal of Cellular and Molecular Medicine
|
February 21, 2009
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
Monika Jung, Hans-Joachim Mollenkopf, Christina Grimm, et al.
The American Journal of Pathology
|
March 26, 2011
The androgen-regulated Calcium-Activated Nucleotidase 1 (CANT1) is commonly overexpressed in prostate cancer and is tumor-biologically relevant in vitro
Josefine Gerhardt, Corinna Steinbrech, Oralea Büchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 18, 2015
The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer
Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz, et al.
Oncotarget
|
December 2, 2015
Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer
Sebastian Meller, Hellmuth-A Meyer, Bianca Bethan, et al.
Oncogene
|
September 4, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis
Mohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy, et al.
Plos One
|
April 26, 2012
MiR-133b targets antiapoptotic genes and enhances death receptor-induced apoptosis
Juan P Patron, Annika Fendler, Matthias Bild, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
January 30, 2024
Clinical implications of AGR2 in primary prostate cancer: Results from a large-scale study
Moritz Wambach, Matteo Montani, Josefine Runz, et al.
Page
of 23